• Startseite
• rv spike
• Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes

Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes

4.8 (386) · € 26.00 · Auf Lager

Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein

Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach

Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus–Host Interaction and Pathogenesis

Coronaviruses — drug discovery and therapeutic options

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape - The Lancet Infectious Diseases

SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern

SARS-CoV-2 Vaccine Development: An Overview and Perspectives

Rotavirus as an Expression Platform of the SARS-CoV-2 Spike Protein